Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.

Por Schadendorf, D., Fichtner, I., Makki, A., Alijagic, S., Küpper, M., Mrowietz, U., Henz, B. M.
Publicado em 1996

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

Por Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.
Publicado no Arch Dermatol Res (2015)

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice

Por Mrowietz, U, Schwenk, U, Maune, S, Bartels, J, Küpper, M, Fichtner, I, Schröder, J-M, Schadendorf, D
Publicado em 1999

Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS)

Por Lamprecht, P, Moosig, F, Adam-Klages, S, Mrowietz, U, Csernok, E, Kirrstetter, M, Ahmadi-Simab, K, Schroder, J, Gross, W
Publicado em 2004

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Stu...

Por Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., Leonardi, C., Mrowietz, U.
Publicado no J Eur Acad Dermatol Venereol (2018)

The German National Program on Psoriasis Health Care 2005–2015: results and experiences

Por Augustin, M., Eissing, L., Langenbruch, A., Enk, A., Luger, T., Maaßen, D., Mrowietz, U., Reich, K., Reusch, M., Strömer, K., Thaçi , D., von Kiedrowski, R., Radtke, M. A.
Publicado no Arch Dermatol Res (2016)

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Por Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Publicado no J Eur Acad Dermatol Venereol (2017)

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Por Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B., Yawalkar, N.
Publicado em 2010

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)

Por Nast, A., Kopp, I., Augustin, M., Banditt, K. B., Boehncke, W. H., Follmann, M., Friedrich, M., Huber, M., Kahl, C., Klaus, J., Koza, J., Kreiselmaier, I., Mohr, J., Mrowietz, U., Ockenfels, H. M., Orzechowski, H. D., Prinz, J., Reich, K., Rosenbach, T., Rosumeck, S., Schlaeger, M., Schmid-Ott, G., Sebastian, M., Streit, V., Weberschock, T., Rzany, B.
Publicado em 2007